|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Litigation costs, net | |||||
| Total operating expenses | |||||
| Loss from continuing operations | |||||
| Interest expense | |||||
| Interest expense, net | |||||
| Interest (income) expense, net | |||||
| (Gain) loss on revaluation of warrant liability | |||||
| Other expense (income), net | |||||
| Loss from continuing operations before provision for income taxes | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| (Income) loss from discontinued operations | |||||
| Net income (loss) | |||||
| Net loss attributable to common stockholders | |||||
| Less: dilutive gain on revaluation of warrant liability | |||||
| Net income (loss) for dilutive earnings per share | |||||
| Net loss from continuing operations per share - basic (in dollars per share) | |||||
| Net loss from continuing operations per share - diluted (in dollars per share) | |||||
| Net income (loss) from discontinued operations per share - basic (in dollars per share) | |||||
| Net income (loss) from discontinued operations per share - diluted (In dollars per share) | |||||
| Net income (loss) per share - basic (in dollar per share) | |||||
| Net income (loss) per share - diluted (in dollar per share) | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - diluted (in shares) |
Loading...